Literature DB >> 12879945

Diabetes mellitus is associated with insufficient microvascular reperfusion following revascularization for anterior acute myocardial infarction.

Satoshi Kurisu1, Ichiro Inoue, Takuji Kawagoe, Masaharu Ishihara, Yuji Shimatani, Kenji Nishioka, Takashi Umemura, Suji Nakamura, Masashi Yoshida.   

Abstract

OBJECTIVE: The purpose of this study was to test the hypothesis that lack of microvascular reperfusion following revascularization might be associated with a poor clinical outcome in diabetic patients with acute myocardial infarction (AMI).
METHODS: We studied 134 patients with a first anterior AMI who underwent successful revascularization within 6 hours. We assessed microvascular reperfusion by using electrocardiogram recordings just before revascularization and on return to the coronary care unit. Lack of microvascular reperfusion was defined as the absence of decrease of > or = 20% in the sum of ST segment elevation (sigmaST).
RESULTS: Twenty-four patients had diabetes and 110 patients did not. SigmaST before revascularization was similar between diabetic and nondiabetic patients. After revascularization, reduction of sigmaST was significantly smaller (1.3 +/- 8.4 mm vs 6.5 +/- 10.8 mm, p = 0.03), and lack of microvascular reperfusion was significantly more frequent (62.5% vs 33.6%, p = 0.01) in diabetic patients. A multivariate analysis showed that diabetes was associated with insufficient microvascular reperfusion (odds ratio 3.18, p = 0.03). Major adverse cardiac events occurred more frequently in patients with a lack of microvascular reperfusion (30.8% vs 15.9%, p = 0.04).
CONCLUSION: These findings suggest that lack of microvascular reperfusion following revascularization may be one of the mechanisms of a poor clinical outcome in diabetic patients with AMI.

Entities:  

Mesh:

Year:  2003        PMID: 12879945     DOI: 10.2169/internalmedicine.42.554

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  5 in total

1.  Downregulation of BK channel function and protein expression in coronary arteriolar smooth muscle cells of type 2 diabetic patients.

Authors:  Tong Lu; Qiang Chai; Guoqing Jiao; Xiao-Li Wang; Xiaojing Sun; Jonathan D Furuseth; John M Stulak; Richard C Daly; Kevin L Greason; Yong-Mei Cha; Hon-Chi Lee
Journal:  Cardiovasc Res       Date:  2019-01-01       Impact factor: 10.787

Review 2.  Coronary microvascular dysfunction in diabetes mellitus.

Authors:  Aleksandar Kibel; Kristina Selthofer-Relatic; Ines Drenjancevic; Tatjana Bacun; Ivica Bosnjak; Dijana Kibel; Mario Gros
Journal:  J Int Med Res       Date:  2017-01-12       Impact factor: 1.671

3.  Regulation of coronary arterial BK channels by caveolae-mediated angiotensin II signaling in diabetes mellitus.

Authors:  Tong Lu; Dai-Min Zhang; Xiao-Li Wang; Tongrong He; Ru-Xing Wang; Qiang Chai; Zvonimir S Katusic; Hon-Chi Lee
Journal:  Circ Res       Date:  2010-02-18       Impact factor: 17.367

Review 4.  The assessment of endothelial function: from research into clinical practice.

Authors:  Andreas J Flammer; Todd Anderson; David S Celermajer; Mark A Creager; John Deanfield; Peter Ganz; Naomi M Hamburg; Thomas F Lüscher; Michael Shechter; Stefano Taddei; Joseph A Vita; Amir Lerman
Journal:  Circulation       Date:  2012-08-07       Impact factor: 29.690

Review 5.  Rhizoma coptidis as a Potential Treatment Agent for Type 2 Diabetes Mellitus and the Underlying Mechanisms: A Review.

Authors:  Qian Ran; Jin Wang; Lin Wang; Hai-Rong Zeng; Xiang-Bo Yang; Qin-Wan Huang
Journal:  Front Pharmacol       Date:  2019-07-22       Impact factor: 5.810

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.